Stock Events

Stock Events

Search...

Regulus Therapeutics (7RG0.F) Q3 2024 Earnings

8AugConfirmed

Q2 2024

Q3 2024

-0.27

-0.22

-0.18

-0.13

Details

Expected EPS

-0.13434843867

Actual EPS

-0.15572170000000002

Surprise EPS

-0.02

Surprise Percent

+15.91%

Description

Regulus Therapeutics (7RG0.F) has reported earnings of -0.15572170000000002 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.